Apparatus and methods for controlled substance delivery from implanted prostheses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6939375
APP PUB NO 20020082685A1
SERIAL NO

09783253

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides improved devices and methods for inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides luminal prostheses which allow for programmed and controlled substance delivery with increased efficacy to selected locations within a patient's vasculature to inhibit restenosis. The luminal delivery prosthesis comprises a scaffold which is implantable within a body lumen and means on the scaffold for releasing a substance from the scaffold. The substance is released over a predetermined time pattern comprising an initial phase wherein the substance delivery rate is below a threshold level and a subsequent phase wherein the substance delivery rate is above a threshold level.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVANTEC VASCULAR CORPORATIONSUITE 103 1440 KOLL CIRCLE SAN JOSE CA 95112

International Classification(s)

  • Non-US Classification not provided for expired patents

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sirhan, Motasim Sunnyvale, CA 56 2387
Yan, John Los Gatos, CA 116 3705

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • Citation Ranking not provided for expired patents

Forward Cite Landscape

Load Citation